rare disease data center
Rare Disease Data Center vs Slow Trials Cut 35%
In 2024, the ARC program funded 12 gene-therapy trials, shortening design phases by 30% and cutting enrollment delays for rare diseases. This initiative merges cloud-native data pipelines with AI-driven patient stratification. Takeaway: ARC reshapes the rare-disease landscape by delivering faster, more efficient trials. Medical Disclaimer: This article is for informational